Tyler Rasmussen
Cardiovascular Disease · Cedar Rapids, IANPI 1265880454
Payments from drug & device makers
What this record shows
This record is dominated by grants: $28,136 of the $37,177 with a category attached, or 75.7%. 17 manufacturers reported payments, led by Abbott at 43.0% of the total. Reporting peaked in 2022 at $17,143 and has fallen 97.3% since, to $462 in 2025. Among cardiovascular disease clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $163.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$16K
- Boston Scientific$14K
- Medtronic$5K
- Biosense Webster, Inc.$581
- Impulse Dynamics (USA) Inc.$559
- Philips North America LLC$245
- plus $767 from 11 others
What the payments were for
- Grants$28,13676%
- Travel & lodging$3,2549%
- Food & beverage$4,96013%
- Education$8272%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 58 | $15,995 |
| Boston Scientific | 89 | $14,390 |
| Medtronic | 16 | $4,640 |
| Biosense Webster, Inc. | 21 | $581 |
| Impulse Dynamics (USA) Inc. | 13 | $559 |
| Philips North America LLC | 6 | $245 |
| Abiomed | 3 | $182 |
| Cardiva Medical, Inc. | 6 | $146 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $95 |
| Atricure, Inc. | 1 | $95 |
| Sanofi-aventis U.S. LLC | 1 | $59 |
| Getinge USA Sales, LLC | 3 | $51 |
| Edwards Lifesciences | 1 | $45 |
| Elutia, Inc. | 3 | $40 |
| Shockwave Medical, Inc | 1 | $23 |
| Biotronik Inc. | 1 | $15 |
| Livanova USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM MRI S-ICD$7,500
- Micra$1,731
- AVEIR$1,351
- OPTIMIZER$639
- ENSITE$483
- Adapta$206
- RESONATE EL ICD VR$155
- Impella$146
- Optis Coronary Imaging System$137
- Carto 3$133
How this compares
$37,177 in reported general payments places this provider in the 95th percentile of 142 cardiovascular disease providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $21,640 |
| Amiodarone Hcl | 14 | $139 |
| Metoprolol Succinate | 11 | $99 |
| Pantoprazole Sodium | 13 | $47 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Cedar Rapids
- Matthew McMahonCedar Rapids$35K
- Rohan PenmetchaCedar Rapids$5K
- Amandeep Singh DhaliwalCedar Rapids$2K
- Brian OlshanskyIowa City$219K
- Troy HounshellWest Des Moines$164K
- Enrico MartinWest Des Moines$113K
- Gursukhman Deep SidhuDavenport$60K
- Suzanne FeigofskyWest Des Moines$59K
- Jennifer RobinsonIowa City$37K
- Craig StarkDes Moines$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.